Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

8 treatments under study, led by Qswitched Sinon Ruby Laser

Research Leaders

7 sponsors active, led by University of Zurich

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 37/100

Termination Rate

0.0%

0 terminated out of 6 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

40%

2 of 5 completed with results

Key Signals

2 with results100% success

Data Visualizations

Phase Distribution

6Total
Not Applicable (5)
Phase 2 (1)

Trial Status

Completed5
Unknown1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 5 completed trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT04583852Not ApplicableCompletedPrimary

Evaluate the Efficacy and Safety of Brightening Micro-needle Patch on Facial Solar Lentigines

NCT01778179Not ApplicableCompletedPrimary

A Fixed Triple Combination Cream for Solar Lentigines Associated to Cryotherapy

NCT01885871Not ApplicableCompletedPrimary

Laser Removal of Age (Sun) Spots on Hands

NCT02153697Not ApplicableCompletedPrimary

Comparative Study of the Therapy of Solar Lentigines With a Q-switched Rubin Laser Versus a Bleaching Cream

NCT01249469Not ApplicableUnknownPrimary

Evaluate the Lightening Effect of the Whitening Cosmetic Product BEX-2011

NCT00386204Phase 2CompletedPrimary

Side Effects of Q-Switched Ruby Laser for the Treatment of Lentigines in Light and Dark Skin Types

Showing all 6 trials

Research Network

Common Treatments

  • Qswitched Sinon Ruby Laser1
  • Aivía Ultrabrightening Spot Microneedle Patch1
  • Skin Whitening Cosmetic Product1
  • Picosecond Qs Ndyag Laser1
  • Pigmanorm Cream1

Active Sponsors

  • University of Zurich1
  • Shahid Beheshti University of Medical Sciences1
  • L'Oreal1
  • Hexsel Dermatology Clinic1
  • Cutera Inc.1

Top Investigators

Activity Timeline